KANG

作品数：93被引量：115H指数：6
导出分析报告
相关领域：历史地理医药卫生更多>>
相关作者：王士同蒋亦樟邓赵红于云鹏史荧中更多>>
相关机构：江南大学国立台北科技大学文山学院西安外国语大学更多>>
相关期刊：更多>>
相关基金：国家自然科学基金江苏省自然科学基金教育部“新世纪优秀人才支持计划”国家重点基础研究发展计划更多>>
-
在结果中检索

检索结果分析

结果分析中...
选择条件：
  • 期刊=Chinese Journal of Integrative Medicinex
共 条 记 录，以下是1-4
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Mechanism of Fuzheng Kang'ai Formula Regulating Tumor Microenvironment in Non-Small Cell Lung Cancer
《Chinese Journal of Integrative Medicine》2022年第5期425-433,共9页TIAN Yun-ling FU Song-bo LI Bo YUAN Ling-yan BING Zhi-tong 
Supported by the Special Funds of Science and Technology Development of the Chinese Central Government to Guide Local in 2020(No.21JR1RA066,20JR10FA667);Hospital Fund of the First Hospital of Lanzhou University(No.ldyyyn2007-03)。
Objective:To study the mechanism of Chinese herbal medicine Fuzheng Kang’ai Formula(FZKA)on tumor microenvironment(TME).Methods:CIBERSORTx was used for analysis of TME.Traditional Chinese Medicine Systems Pharmacolog...
关键词：network pharmacology PROGNOSIS tumor microenvironment Fuzheng Kang’ai Formula Chinese medicine lung adenocarcinoma 
Gefitinib plus Fuzheng Kang'ai Formula(扶正抗癌方) in Patients with Advanced Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation:A Randomized Controlled Trial被引量：19
《Chinese Journal of Integrative Medicine》2018年第10期734-740,共7页YANG Xiao-bing CHAI Xiao-shu WU Wan-yin LONG Shun-qin DENG Hong PAN Zong-qi HE Wen-feng ZHOU Yu-shu LIAO Gui-ya XIAO Shu-jing 
Supported by the National Natural Science Foundation of China(No.81273965,81503507);the Natural Science Foundation of Guangdong Province(No.2015A030310245)
Objective： To evaluate the effect of Fuzheng Kang＇ai Formula （扶正抗癌方, FZKA） plus gefitinib in patients with advanced non-small cell lung cancer with epidermal growth factor receptor （EGFR） mutations. Methods...
关键词：non-small cell lung cancer GEFITINIB Chinese medicine combination therapy sensitizing effect Fuzheng Kang＇ai Formula randomized controlled trial 
Effect of Kang’ai Injection (康艾注射液) on Serum Level of Soluble Interleukin-2 Receptor and Vascular Endothelial Growth Factor in Patients with Esophageal Carcinoma during Radiotherapy被引量：5
《Chinese Journal of Integrative Medicine》2006年第4期273-276,共4页何泽锋 王建军 汪文东 
Objective： To observe the effect of Kang＇ai Injection （康艾注射液, KAI） on serum level of soluble interleukin-2 receptor （sIL-2R） and vascular endothelial growth factor （VEGF） in patients with esophageal carci...
关键词：soluble interleukin-2 receptor vascular endothelial growth factor esophageal carcinoma radiotherapy Kang＇ai Injection sensitivity enhancing 
Clinical Study on Effect of Kang'aibao Oral Liquid(抗癌宝口服液) in Treating 103 Patients of Malignant Tumor
《Chinese Journal of Integrative Medicine》1999年第4期261-264,共4页王怀璋 林焯唐 
Objective: To observe the clinical efficacy of Kang'aibao oral liquid (KABL), a Chinese herbal preparation in treating malignant tumor of middle or advanced stage. Methods: A comparative study was done by observing th...
关键词：malignant tumor of middle or advanced stage Kang'aibao oral liquid survival time survival quality 
全选清除导出
共1页<1>
检索报告 对象比较 聚类工具 使用帮助 返回顶部